Karishma Selvaraj

Over the past year, the demand for weight loss medications has increased dramatically and so-called "skinny jab" drugs (GLP-1 receptor agonists Wegovy, Ozempic, and Mounjaro) have consistently struggled to avoid drug shortages. This